Bone markers and cardiovascular risk in type 2 diabetes patients.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Zwakenberg, Sabine Rvan der Schouw, Yvonne T
Schalkwijk, Casper G
Spijkerman, Annemieke M W
Beulens, Joline W J
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Bone markers and cardiovascular risk in type 2 diabetes patients.Published in
Cardiovasc Diabetol 2018; 17(1):45Publiekssamenvatting
Vascular calcifications are associated with a three- to fourfold increased risk of cardiovascular disease (CVD) and are highly prevalent in type 2 diabetes patients. Emerging evidence indicates that vascular calcification is a process of active bone formation regulated by stimulators and inhibitors of calcification. Therefore, this study aimed to evaluate whether six bone markers are associated with CVD risk in patients with type 2 diabetes.ae974a485f413a2113503eed53cd6c53
10.1186/s12933-018-0691-2
Scopus Count
Collections
Related articles
- Biomarkers of vascular calcification and mortality in patients with ESRD.
- Authors: Scialla JJ, Kao WH, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, Coresh J, Powe NR, Plantinga LC, Jaar BG, Parekh RS
- Issue date: 2014 Apr
- Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL).
- Authors: Hanssen NM, Beulens JW, van Dieren S, Scheijen JL, van der A DL, Spijkerman AM, van der Schouw YT, Stehouwer CD, Schalkwijk CG
- Issue date: 2015 Jan
- The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
- Authors: Bots SH, van der Graaf Y, Nathoe HM, de Borst GJ, Kappelle JL, Visseren FL, Westerink J, SMART Study Group.
- Issue date: 2016 Jul 19
- Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus.
- Authors: van der Leeuw J, Beulens JW, van Dieren S, Schalkwijk CG, Glatz JF, Hofker MH, Verschuren WM, Boer JM, van der Graaf Y, Visseren FL, Peelen LM, van der Schouw YT
- Issue date: 2016 May 31
- Calcification of the splenic, iliac, and breast arteries and risk of all-cause and cardiovascular mortality.
- Authors: Hendriks EJ, Beulens JW, de Jong PA, van der Schouw YT, Sun WN, Wright CM, Criqui MH, Allison MA, Ix JH
- Issue date: 2017 Apr